Publications by authors named "Jinro Abe"

Background/aims: In patients with active ulcerative colitis (UC), pharmacologics, although initially effective in most patients, are associated with refractoriness, loss of response or unfavourable side effects as additional morbidity factors. Depletion of myeloid lineage leucocytes like the CD14(+)CD16(+) monocyte phenotype, which is a major source of tumour necrosis factor-α, by granulocyte/monocyte apheresis (GMA) if effective, is also known to be free from side effects.

Methods: In clinical practice setting, 77 consecutive patients with moderate to severe UC, who failed to respond to first-line medications received GMA with the Adacolumn as remission induction therapy.

View Article and Find Full Text PDF
Article Synopsis
  • Cytomegalovirus (CMV) is often found in patients with ulcerative colitis (UC) who do not respond to corticosteroid treatment, suggesting a possible link between CMV infection and severe UC.
  • A study involving 187 patients identified CMV status through various tests, revealing that a significant number of patients in both corticosteroid-free and corticosteroid-refractory groups tested positive for CMV antibodies and antigen.
  • Despite similar colonoscopic findings in CMV-positive and negative patients, the research concluded that CMV reactivation may be influenced by immunosuppressive medications, contributing to UC exacerbation and steroid refractoriness but without definitive unique colonoscopic markers for CMV.
View Article and Find Full Text PDF

Autoimmune hepatitis (AIH) is a disorder of unknown etiology, which often progresses to cirrhosis and carries a high mortality, even though its treatment with corticosteroids has become common. Hepatocellular carcinoma (HCC) has been reported as a rare complication of AIH. We describe herein a patient with HCC associated with AIH, in whom microwave coagulation therapy provided a means of definitive management, and we also review the literature.

View Article and Find Full Text PDF

We examined the relationship between host as well as tumor factors and postoperative survival rate in patients who received combination therapy of mitomycin C + fluoropyrimidine oral antineoplastics + protein-bound polysaccharide K (PSK) (MFP therapy) after curative resection of colorectal cancer. Markers that determine prognosis, such as preoperative humoral factors (complement 3 and 4), immunosuppressive acidic protein (IAP), lymphocyte transformation (cellular factors) induced by phytohemagglutinin (PHA), pokeweed mitogen (PWM), and PSK, and various tumor markers (CEA, CA19-9) were measured. For each parameter, patients were divided into a high-level and a low-level group according to a predetermined cut-off value, and survival rates were compared between the two groups.

View Article and Find Full Text PDF